Global EPO Biomarkers Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 116 pages | ID: GCBC59379BCEN
GlobalInfoResearch

Abstracts

Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow.

Scope of the Report:

Major factors contributing to the growth of the global EPO biomarkers market include increasing sedentary lifestyle and faulty dietary habits has increased the prevalence of cancers and chronic kidney diseases in the emerged economies. Moreover, the increasing incidence of end-stage renal disorders and hematological diseases is further increasing the demand for EPO biomarkers.
The global EPO Biomarkers market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of EPO Biomarkers.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the EPO Biomarkers market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the EPO Biomarkers market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Siemens
• Thermo Fisher Scientific
• Pfizer
• Novartis
• Johnson & Johnson
• Merck
• LG Life Sciences India
• Amgen
• Roche
• Agilent

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Erythropoietin alfa
• Erythropoietin beta
• Erythropoietin zeta
• Erythropoietin theta
• Recombinant human erythropoietin
• Darbepoietin alfa

Market Segment by Applications, can be divided into

• Diagnostic centers
• Ambulatory care and surgical centers
• Hospitals

Contents

1 EPO BIOMARKERS MARKET OVERVIEW

1.1 Product Overview and Scope of EPO Biomarkers
1.2 Classification of EPO Biomarkers by Types
  1.2.1 Global EPO Biomarkers Revenue Comparison by Types (2017-2023)
  1.2.2 Global EPO Biomarkers Revenue Market Share by Types in 2017
  1.2.3 Erythropoietin alfa
  1.2.4 Erythropoietin beta
  1.2.5 Erythropoietin zeta
  1.2.6 Erythropoietin theta
  1.2.7 Recombinant human erythropoietin
  1.2.8 Darbepoietin alfa
1.3 Global EPO Biomarkers Market by Application
  1.3.1 Global EPO Biomarkers Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Diagnostic centers
  1.3.3 Ambulatory care and surgical centers
  1.3.4 Hospitals
1.4 Global EPO Biomarkers Market by Regions
  1.4.1 Global EPO Biomarkers Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) EPO Biomarkers Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) EPO Biomarkers Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) EPO Biomarkers Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) EPO Biomarkers Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) EPO Biomarkers Status and Prospect (2013-2023)
1.5 Global Market Size of EPO Biomarkers (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Siemens
  2.1.1 Business Overview
  2.1.2 EPO Biomarkers Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Siemens EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.2 Thermo Fisher Scientific
  2.2.1 Business Overview
  2.2.2 EPO Biomarkers Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Thermo Fisher Scientific EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
  2.3.1 Business Overview
  2.3.2 EPO Biomarkers Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Pfizer EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
  2.4.1 Business Overview
  2.4.2 EPO Biomarkers Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Novartis EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
  2.5.1 Business Overview
  2.5.2 EPO Biomarkers Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Johnson & Johnson EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
  2.6.1 Business Overview
  2.6.2 EPO Biomarkers Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Merck EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.7 LG Life Sciences India
  2.7.1 Business Overview
  2.7.2 EPO Biomarkers Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 LG Life Sciences India EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.8 Amgen
  2.8.1 Business Overview
  2.8.2 EPO Biomarkers Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Amgen EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.9 Roche
  2.9.1 Business Overview
  2.9.2 EPO Biomarkers Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Roche EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.10 Agilent
  2.10.1 Business Overview
  2.10.2 EPO Biomarkers Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Agilent EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL EPO BIOMARKERS MARKET COMPETITION, BY PLAYERS

3.1 Global EPO Biomarkers Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 EPO Biomarkers Players Market Share
  3.2.2 Top 10 EPO Biomarkers Players Market Share
3.3 Market Competition Trend

4 GLOBAL EPO BIOMARKERS MARKET SIZE BY REGIONS

4.1 Global EPO Biomarkers Revenue and Market Share by Regions
4.2 North America EPO Biomarkers Revenue and Growth Rate (2013-2018)
4.3 Europe EPO Biomarkers Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific EPO Biomarkers Revenue and Growth Rate (2013-2018)
4.5 South America EPO Biomarkers Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa EPO Biomarkers Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA EPO BIOMARKERS REVENUE BY COUNTRIES

5.1 North America EPO Biomarkers Revenue by Countries (2013-2018)
5.2 USA EPO Biomarkers Revenue and Growth Rate (2013-2018)
5.3 Canada EPO Biomarkers Revenue and Growth Rate (2013-2018)
5.4 Mexico EPO Biomarkers Revenue and Growth Rate (2013-2018)

6 EUROPE EPO BIOMARKERS REVENUE BY COUNTRIES

6.1 Europe EPO Biomarkers Revenue by Countries (2013-2018)
6.2 Germany EPO Biomarkers Revenue and Growth Rate (2013-2018)
6.3 UK EPO Biomarkers Revenue and Growth Rate (2013-2018)
6.4 France EPO Biomarkers Revenue and Growth Rate (2013-2018)
6.5 Russia EPO Biomarkers Revenue and Growth Rate (2013-2018)
6.6 Italy EPO Biomarkers Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC EPO BIOMARKERS REVENUE BY COUNTRIES

7.1 Asia-Pacific EPO Biomarkers Revenue by Countries (2013-2018)
7.2 China EPO Biomarkers Revenue and Growth Rate (2013-2018)
7.3 Japan EPO Biomarkers Revenue and Growth Rate (2013-2018)
7.4 Korea EPO Biomarkers Revenue and Growth Rate (2013-2018)
7.5 India EPO Biomarkers Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia EPO Biomarkers Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA EPO BIOMARKERS REVENUE BY COUNTRIES

8.1 South America EPO Biomarkers Revenue by Countries (2013-2018)
8.2 Brazil EPO Biomarkers Revenue and Growth Rate (2013-2018)
8.3 Argentina EPO Biomarkers Revenue and Growth Rate (2013-2018)
8.4 Colombia EPO Biomarkers Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE EPO BIOMARKERS BY COUNTRIES

9.1 Middle East and Africa EPO Biomarkers Revenue by Countries (2013-2018)
9.2 Saudi Arabia EPO Biomarkers Revenue and Growth Rate (2013-2018)
9.3 UAE EPO Biomarkers Revenue and Growth Rate (2013-2018)
9.4 Egypt EPO Biomarkers Revenue and Growth Rate (2013-2018)
9.5 Nigeria EPO Biomarkers Revenue and Growth Rate (2013-2018)
9.6 South Africa EPO Biomarkers Revenue and Growth Rate (2013-2018)

10 GLOBAL EPO BIOMARKERS MARKET SEGMENT BY TYPE

10.1 Global EPO Biomarkers Revenue and Market Share by Type (2013-2018)
10.2 Global EPO Biomarkers Market Forecast by Type (2018-2023)
10.3 Erythropoietin alfa Revenue Growth Rate (2013-2023)
10.4 Erythropoietin beta Revenue Growth Rate (2013-2023)
10.5 Erythropoietin zeta Revenue Growth Rate (2013-2023)
10.6 Erythropoietin theta Revenue Growth Rate (2013-2023)
10.7 Recombinant human erythropoietin Revenue Growth Rate (2013-2023)
10.8 Darbepoietin alfa Revenue Growth Rate (2013-2023)

11 GLOBAL EPO BIOMARKERS MARKET SEGMENT BY APPLICATION

11.1 Global EPO Biomarkers Revenue Market Share by Application (2013-2018)
11.2 EPO Biomarkers Market Forecast by Application (2018-2023)
11.3 Diagnostic centers Revenue Growth (2013-2018)
11.4 Ambulatory care and surgical centers Revenue Growth (2013-2018)
11.5 Hospitals Revenue Growth (2013-2018)

12 GLOBAL EPO BIOMARKERS MARKET SIZE FORECAST (2018-2023)

12.1 Global EPO Biomarkers Market Size Forecast (2018-2023)
12.2 Global EPO Biomarkers Market Forecast by Regions (2018-2023)
12.3 North America EPO Biomarkers Revenue Market Forecast (2018-2023)
12.4 Europe EPO Biomarkers Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific EPO Biomarkers Revenue Market Forecast (2018-2023)
12.6 South America EPO Biomarkers Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa EPO Biomarkers Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure EPO Biomarkers Picture
Table Product Specifications of EPO Biomarkers
Table Global EPO Biomarkers and Revenue (Million USD) Market Split by Product Type
Figure Global EPO Biomarkers Revenue Market Share by Types in 2017
Figure Erythropoietin alfa Picture
Figure Erythropoietin beta Picture
Figure Erythropoietin zeta Picture
Figure Erythropoietin theta Picture
Figure Recombinant human erythropoietin Picture
Figure Darbepoietin alfa Picture
Table Global EPO Biomarkers Revenue (Million USD) by Application (2013-2023)
Figure EPO Biomarkers Revenue Market Share by Applications in 2017
Figure Diagnostic centers Picture
Figure Ambulatory care and surgical centers Picture
Figure Hospitals Picture
Table Global Market EPO Biomarkers Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America EPO Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe EPO Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific EPO Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America EPO Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa EPO Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global EPO Biomarkers Revenue (Million USD) and Growth Rate (2013-2023)
Table Siemens Basic Information, Manufacturing Base and Competitors
Table Siemens EPO Biomarkers Type and Applications
Table Siemens EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific EPO Biomarkers Type and Applications
Table Thermo Fisher Scientific EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer EPO Biomarkers Type and Applications
Table Pfizer EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis EPO Biomarkers Type and Applications
Table Novartis EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson EPO Biomarkers Type and Applications
Table Johnson & Johnson EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck EPO Biomarkers Type and Applications
Table Merck EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table LG Life Sciences India Basic Information, Manufacturing Base and Competitors
Table LG Life Sciences India EPO Biomarkers Type and Applications
Table LG Life Sciences India EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen EPO Biomarkers Type and Applications
Table Amgen EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche EPO Biomarkers Type and Applications
Table Roche EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Basic Information, Manufacturing Base and Competitors
Table Agilent EPO Biomarkers Type and Applications
Table Agilent EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
Table Global EPO Biomarkers Revenue (Million USD) by Players (2013-2018)
Table Global EPO Biomarkers Revenue Share by Players (2013-2018)
Figure Global EPO Biomarkers Revenue Share by Players in 2016
Figure Global EPO Biomarkers Revenue Share by Players in 2017
Figure Global Top 5 Players EPO Biomarkers Revenue Market Share in 2017
Figure Global Top 10 Players EPO Biomarkers Revenue Market Share in 2017
Figure Global EPO Biomarkers Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global EPO Biomarkers Revenue (Million USD) by Regions (2013-2018)
Table Global EPO Biomarkers Revenue Market Share by Regions (2013-2018)
Figure Global EPO Biomarkers Revenue Market Share by Regions (2013-2018)
Figure Global EPO Biomarkers Revenue Market Share by Regions in 2017
Figure North America EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Europe EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure South America EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa EPO Biomarkers Revenue and Growth Rate (2013-2018)
Table North America EPO Biomarkers Revenue by Countries (2013-2018)
Table North America EPO Biomarkers Revenue Market Share by Countries (2013-2018)
Figure North America EPO Biomarkers Revenue Market Share by Countries (2013-2018)
Figure North America EPO Biomarkers Revenue Market Share by Countries in 2017
Figure USA EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Canada EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Mexico EPO Biomarkers Revenue and Growth Rate (2013-2018)
Table Europe EPO Biomarkers Revenue (Million USD) by Countries (2013-2018)
Figure Europe EPO Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Europe EPO Biomarkers Revenue Market Share by Countries in 2017
Figure Germany EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure UK EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure France EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Russia EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Italy EPO Biomarkers Revenue and Growth Rate (2013-2018)
Table Asia-Pacific EPO Biomarkers Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific EPO Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific EPO Biomarkers Revenue Market Share by Countries in 2017
Figure China EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Japan EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Korea EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure India EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Southeast Asia EPO Biomarkers Revenue and Growth Rate (2013-2018)
Table South America EPO Biomarkers Revenue by Countries (2013-2018)
Table South America EPO Biomarkers Revenue Market Share by Countries (2013-2018)
Figure South America EPO Biomarkers Revenue Market Share by Countries (2013-2018)
Figure South America EPO Biomarkers Revenue Market Share by Countries in 2017
Figure Brazil EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Argentina EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Colombia EPO Biomarkers Revenue and Growth Rate (2013-2018)
Table Middle East and Africa EPO Biomarkers Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa EPO Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa EPO Biomarkers Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa EPO Biomarkers Revenue Market Share by Countries in 2017
Figure Saudi Arabia EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure UAE EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Egypt EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure Nigeria EPO Biomarkers Revenue and Growth Rate (2013-2018)
Figure South Africa EPO Biomarkers Revenue and Growth Rate (2013-2018)
Table Global EPO Biomarkers Revenue (Million USD) by Type (2013-2018)
Table Global EPO Biomarkers Revenue Share by Type (2013-2018)
Figure Global EPO Biomarkers Revenue Share by Type (2013-2018)
Figure Global EPO Biomarkers Revenue Share by Type in 2017
Table Global EPO Biomarkers Revenue Forecast by Type (2018-2023)
Figure Global EPO Biomarkers Market Share Forecast by Type (2018-2023)
Figure Global Erythropoietin alfa Revenue Growth Rate (2013-2018)
Figure Global Erythropoietin beta Revenue Growth Rate (2013-2018)
Figure Global Erythropoietin zeta Revenue Growth Rate (2013-2018)
Figure Global Erythropoietin theta Revenue Growth Rate (2013-2018)
Figure Global Recombinant human erythropoietin Revenue Growth Rate (2013-2018)
Figure Global Darbepoietin alfa Revenue Growth Rate (2013-2018)
Table Global EPO Biomarkers Revenue by Application (2013-2018)
Table Global EPO Biomarkers Revenue Share by Application (2013-2018)
Figure Global EPO Biomarkers Revenue Share by Application (2013-2018)
Figure Global EPO Biomarkers Revenue Share by Application in 2017
Table Global EPO Biomarkers Revenue Forecast by Application (2018-2023)
Figure Global EPO Biomarkers Market Share Forecast by Application (2018-2023)
Figure Global Diagnostic centers Revenue Growth Rate (2013-2018)
Figure Global Ambulatory care and surgical centers Revenue Growth Rate (2013-2018)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global EPO Biomarkers Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global EPO Biomarkers Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global EPO Biomarkers Revenue Market Share Forecast by Regions (2018-2023)
Figure North America EPO Biomarkers Revenue Market Forecast (2018-2023)
Figure Europe EPO Biomarkers Revenue Market Forecast (2018-2023)
Figure Asia-Pacific EPO Biomarkers Revenue Market Forecast (2018-2023)
Figure South America EPO Biomarkers Revenue Market Forecast (2018-2023)
Figure Middle East and Africa EPO Biomarkers Revenue Market Forecast (2018-2023)